|
|
|
How The Pieces Add Up: BIB Targets $70 ETF Channel Staff - Wednesday, February 21, 10:12 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $70.12 per unit.
Read More » Analysts Predict 23% Upside For The Holdings of BIB ETF Channel Staff - Monday, February 12, 10:44 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $69.82 per unit.
Read More » Analysts Forecast 32% Upside For BIB ETF Channel Staff - Thursday, November 30, 7:06 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $58.12 per unit.
Read More »
Look Under The Hood: BIB Has 34% Upside ETF Channel Staff - Monday, November 20, 7:14 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $58.13 per unit.
Read More » Implied BIB Analyst Target Price: $67 ETF Channel Staff - Friday, November 10, 9:31 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $66.54 per unit.
Read More » BIB's Underlying Holdings Imply 39% Gain Potential ETF Channel Staff - Thursday, November 2, 7:20 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $59.39 per unit.
Read More » Implied BIB Analyst Target Price: $61 ETF Channel Staff - Wednesday, October 25, 7:04 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $60.61 per unit.
Read More » Nasdaq 100 Movers: EXPE, REGN ETF Channel Staff - Monday, August 28, 10:23 AM
Read More »
Older articles »
|
|
|
|
|